Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain
March 07, 2024 03:00 ET
|
Persica Pharmaceuticals
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held,...
Chronic Lower Back Pain Treatment Market Size [2022-2028] | Industry Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report
January 10, 2022 04:51 ET
|
Fortune Business Insights
Pune, India, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The rising prevalence of chronic pain across the world is expected to drive the global chronic lower back pain treatment market. As per the National...
Researchers Unveil a New Theory Explaining Long-term Pain Relief
March 15, 2021 09:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) -- A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve...
SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA
March 02, 2021 10:45 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of...
Back Pain Wizard Customer Review: Get Lower Back Pain Relief
November 23, 2020 05:00 ET
|
Back Pain Wizard
New York City, NY , Nov. 23, 2020 (GLOBE NEWSWIRE) -- The Back Pain Wizard is a system designed to reinstate muscle balance by releasing the trapped tension in the back and stabilizing the right...
Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration
June 05, 2019 07:00 ET
|
Sorrento Therapeutics, Inc.
ZTlido® gross sales grew from approximately $1 million in March to $2.4 million in April and $3.3 million in MaySP-102 pivotal phase 3 trial remains on track for completion in H1 2020ZTlido® 5.4% (3 X...
SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain
September 25, 2018 10:10 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Christopher Gilmore, MD of Carolinas Pain...
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
August 16, 2018 08:30 ET
|
SPR Therapeutics, Inc.
SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Medical Weight Loss Programs Geared Toward Relieving Lower Back Pain
June 30, 2014 07:00 ET
|
Diet Doc Weight Loss
ESCONDIDO, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Being overweight forces the spine to absorb an extra burden and causes thousands of Americans to suffer lower back pain. Over time, those who are...
POSITIVE SPINAL DISC REPAIR TRIAL RESULTS USING MESOBLAST ADULT STEM CELLS
January 29, 2014 18:31 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced positive 12 month outcome results from the...